Results 81 to 90 of about 4,307,548 (391)

Audit of Typical Prescription Format Among the Prescribers of a Garment Medical Centre in Bangladesh

open access: yesUpdate Dental College Journal, 2013
Objective: To audit the typical prescription or general format according to WHO guidelines for good prescription writing. Materials and methods: A cross-sectional descriptive study was conducted after collecting data from medical records to observe ...
Mohammad Afsan   +4 more
doaj   +1 more source

Daratumumab Treatment for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Case Report

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang   +8 more
wiley   +1 more source

Evidence and Extrapolation: Mechanisms for Regulating Off-Label Uses of Drugs and Devices [PDF]

open access: yes, 2014
A recurring, foundational issue for evidence-based regulation is deciding whether to extend governmental approval from an existing use with sufficient current evidence of safety and efficacy to a novel use for which such evidence is currently lacking ...
Abbott, Ryan, Ayres, Ian
core   +3 more sources

Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Freezing of gait (FOG) in people with Parkinson's disease (PwPD) is debilitating and has limited treatments. Modafinil modulates beta/gamma band activity in the pedunculopontine nucleus (PPN), like PPN deep brain stimulation. We therefore tested the hypothesis that Modafinil would improve FOG in PwPD.
Tuhin Virmani   +8 more
wiley   +1 more source

Prevalence of medicinal drug interactionsin medicinal prescriptions in the Golestan province, Iran (2012)

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2016
Background and Objective: Medicinal drug interactions are one of the problems caused by irrational drug prescription. It eigher change the therapeutic effect or cause drug toxicity.
A Abbasi   +7 more
doaj  

Evaluation of potential drug–drug interactions and its determinants among outpatient prescriptions in six community chain pharmacies in Asmara, Eritrea: a cross-sectional study

open access: yesScientific Reports
Inappropriate prescribing of medicines could result in adverse drug reactions and interactions thereby leading to morbidity and mortality. Potential drug-drug interactions are preventable drug-related problems with the risks of hospitalization, adverse ...
Nuru Abdu   +4 more
doaj   +1 more source

Review Penggunaan Obat Rawat Jalan Peserta Askes Sosial di RSMH Palembang Selama Tahun 2007 Pemberdayaan Masyarakat Bidang Kesehatan di Era Otonomi Daerah [PDF]

open access: yes, 2008
Background: Since 1987 PT Askes has been implementing the drug USAge guideline which is called DPHO (Daftar dan Plafon Harga Obat).In order to encourage drug services efficiently and related to medical needs.
S., Sonlimar M., Sarmalina
core  

How to improve drug dosing for patients with renal impairment in primary care - a cluster-randomized controlled trial [PDF]

open access: yes, 2012
Background: Patients with chronic kidney disease (CKD) are at increased risk for inappropriate or potentially harmful prescribing. The aim of this study was to examine whether a multifaceted intervention including the use of a software programme for the ...
Beyer, Martin   +7 more
core   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy